New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio...
New clinical data from Phio's on-going Phase 1b trial to be presentedMarlborough, Massachusetts--(Newsfile Corp. - October 24, 2024) - Phio...
BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development...
BEIJING, CHINA / ACCESSWIRE / October 24, 2024 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), a biopharmaceutical company specializing in the development...
With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand...
With the potential for explosive profits in a $70 billion industry, CBDL's innovative product line and strategic market positioning stand...
STOCKHOLM, Oct. 24, 2024 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the third quarter...
STOCKHOLM, SE / ACCESSWIRE / October 24, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
MAHWAH, N.J.--(BUSINESS WIRE)--KORU Medical Systems (NASDAQ: KRMD) (“KORU Medical” or the “Company”), a leading medical technology company focused on development,...
HOUSTON, TX / ACCESSWIRE / October 23, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biopharmaceutical company...
NEW YORK, Oct. 23, 2024 /PRNewswire/ -- DeepIntent, the health advertising platform, has been ranked no. 19 by Crain's New York Business...
– Karl Deonanan appointed Chief Financial Officer –– Matt DeZee named to newly established role, Chief Transformation and Strategy Officer – ...
Avantor and NIBRT have formed a new partnership to supply advanced Masterflex® equipment, essential products, and expert training to foster...
KANSAS CITY, Mo., Oct. 23, 2024 /PRNewswire/ -- CRB, a leading provider of sustainable engineering, architecture, construction and consulting services to...
The conference, held in New Jersey, addresses critical aspects of clinical trials in the biopharmaceutical industry in the United States.Rui...
– Preclinical data demonstrate that inhibiting the p300 KAT domain reactivates p53 in HPV-driven tumors resulting in anti-tumor activity –SAN...
Additional 700 Doses Ordered by Mind Medicine Australia as Demand SurgesVancouver, British Columbia--(Newsfile Corp. - October 23, 2024) - Optimi...
FRANKLIN, Mass. and THEALE, UK, Oct. 23, 2024 /PRNewswire/ -- Cold Chain Technologies ("CCT"), a leading global provider of advanced thermal packaging...
STOCKHOLM, SWEDEN / ACCESSWIRE / October 23, 2024 / iZafe Group (STO:IZAFE-B.ST) iZafe Group AB ("iZafe Group") is thrilled to...
Key scientific achievements drive the expansion of the pipeline of molecular glue degraders in fields beyond oncologyEvotec receives a US$...